Quest Pharmatech Stock Today

QPT Stock  CAD 0.06  0.01  14.29%   


0 of 100

Very Weak

Odds Of Distress

Less than 31

Below Average
Quest PharmaTech is selling for under 0.06 as of the 4th of December 2023; that is -14.29 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.06. Quest PharmaTech has about a 31 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Quest PharmaTech are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of November 2023 and ending today, the 4th of December 2023. Click here to learn more.
Quest PharmaTech Inc., a biotechnology company, develops and commercializes antibody based immunotherapeutic products for cancer. The company also owns the Photodynamic therapy technology for oncology and dermatology applications and develops Mab AR 9.6 against truncated O-glycan on MUC16 for targeted cancer therapy applications. The company has 169.13 M outstanding shares of which 534 shares are at this time shorted by private and institutional investors with about 0.06 days to cover all short positions. More on Quest PharmaTech
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Quest Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Quest PharmaTech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Quest PharmaTech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEORagupathy Madiyalakan
Macroaxis Advice
The buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Quest PharmaTech's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellOvervalued
Quest PharmaTech (QPT) is traded on TSX Venture Exchange in Canada and employs 11 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.15 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Quest PharmaTech's market, we take the total number of its shares issued and multiply it by Quest PharmaTech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Quest PharmaTech classifies itself under Biotechnology sector and is part of Health Care industry. The entity has 169.13 M outstanding shares of which 534 shares are at this time shorted by private and institutional investors with about 0.06 days to cover all short positions. Quest PharmaTech has accumulated about 4.41 M in cash with (554.68 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03.
Check Quest PharmaTech Probability Of Bankruptcy
Quest PharmaTech owns a total of one hundred sixty-nine million one hundred twenty-eight thousand nine hundred ninety-two outstanding shares. Quest PharmaTech holds 17.06 pct. of its outstanding shares held by insiders and 0.0 pct. owned by third-party entities. Please note that no matter how much assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.

Ownership Allocation

Check Quest Ownership Details

Quest PharmaTech Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Quest PharmaTech market risk premium is the additional return an investor will receive from holding Quest PharmaTech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Quest PharmaTech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Quest PharmaTech's alpha and beta are two of the key measurements used to evaluate Quest PharmaTech's performance over the market, the standard measures of volatility play an important role as well.

Quest Stock Against Markets

Picking the right benchmark for Quest PharmaTech stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Quest PharmaTech stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Quest PharmaTech is critical whether you are bullish or bearish towards Quest PharmaTech at a given time. Please also check how Quest PharmaTech's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Quest PharmaTech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Pattern Recognition Now


Pattern Recognition

Use different Pattern Recognition models to time the market across multiple global exchanges
All  Next Launch Module

Quest PharmaTech Corporate Directors

Quest PharmaTech corporate directors refer to members of a Quest PharmaTech board of directors. The board of directors generally takes responsibility for the Quest PharmaTech's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Quest PharmaTech's board members must vote for the resolution. The Quest PharmaTech board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Shawn LuDirectorProfile
Eric ShiIndependent DirectorProfile
Ian McConnanIndependent DirectorProfile
Mark LievonenDirectorProfile

How to buy Quest Stock?

Before investing in Quest PharmaTech, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Quest PharmaTech. To buy Quest PharmaTech stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Quest PharmaTech. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Quest PharmaTech stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Quest PharmaTech stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Quest PharmaTech stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Quest PharmaTech, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.

Already Invested in Quest PharmaTech?

The danger of trading Quest PharmaTech is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Quest PharmaTech is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Quest PharmaTech. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Quest PharmaTech is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Quest PharmaTech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Quest Stock analysis

When running Quest PharmaTech's price analysis, check to measure Quest PharmaTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest PharmaTech is operating at the current time. Most of Quest PharmaTech's value examination focuses on studying past and present price action to predict the probability of Quest PharmaTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest PharmaTech's price. Additionally, you may evaluate how the addition of Quest PharmaTech to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Equity Valuation
Check real value of public entities based on technical and fundamental data
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Stocks Directory
Find actively traded stocks across global markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Please note, there is a significant difference between Quest PharmaTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Quest PharmaTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quest PharmaTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.